This study evaluates the hypothesis that ethanol alone, or in diluents for drugs used to protect hypoxic mice, is responsible in part for an increased tolerance to hypoxia (4-5% oxygen). The change in hypoxic tolerance following i.v. or i.p. administration of ethanol, diazepam, nimodipine and various diluent components was measured. Diazepam (50 mg/kg i.v.) increased hypoxic tolerance to 700 ± 47% (n = 11) of saline control, its diluent increased hypoxic tolerance to 468 ± 60% (n = 10) of saline control but the ethanol component of the diluent accounted for almost half of this diluent effect. Nimodipine (2 mg/kg i.p.), a calcium antagonist, increased tolerance to 180 ±18% of control (n = 19) and nimodipine diluent showed an even greater increase to 226 ±25% of control (n = 15). In this case essentially all of the protective effect of nimodipine diluent (81.3%) is accounted for by ethanol. Dose response curves indicate the maximum ethanol induced increase in hypoxic tolerance was approximately 335% of control at a dose of 2.4 g/kg. Buffers, etc. in the diluents evidently add to the protective effect of ethanol. Our data clearly indicate ethanol is the important component of some treatments which protect mice from hypoxia. The pharmacological activity of ethanol, even when used in a diluent, should not be ignored in evaluating therapeutic intervention for protection from hypoxia. by guest on October 30, 2017 http://stroke.ahajournals.org/ Downloaded from 45 FIGURE 2. Nimodipine (2 mg/kg) and its diluent increase hy poxic survival time over saline controls (one star = p < 0.05 and two stars = p < 0.01). The diluent is more effective (one triangle = p < 0.05 and two triangles = p < 0.01) than nimodipine alone. Numbers in parentheses indicate sample by guest on October 30, 2017 http://stroke.ahajournals.org/ Downloaded from 10. Tate RL, Mehlman MA, Tobin RB: Metabolic fate of 1,3-butaned iol in the rat: conversion to beta-hydroxybutyrate.
THE INCREASED SURVIVAL TIME in mice sub jected to hypoxia has been investigated in several labo ratories to identify procedures which may be of thera peutic value in cerebral hypoxia. The importance of these experiments stems from the high morbidity and mortality associated with cerebral hypoxia. The brain appears to be particularly sensitive to hypoxia presum ably because of its high metabolic rate, relatively small stores of high energy phosphates and glucose as well as a relatively low capillary density. 1 Although the cause of death or sequence of events leading to death in the hypoxic mouse model have not been established there is evidence to suggest that during hypoxia the cessation of spontaneous ventilation results from reduced brain activity. Recent work in our laboratory using a Levine rat preparation, which includes on-line monitoring of blood pressure, heart rate, respiratory rate, central ve nous pressure and electroencephalogram, indicates that loss of cerebral electrical activity invariably pre cedes loss of spontaneous respiration and ultimate loss of cardiac activity 2 when an animal is exposed to hy poxia. In contrast it has been shown that cardiac func tion is maintained during hypoxia because coronary blood flow is increased by local mechanisms in order to maintain a relatively constant myocardial oxygen tension. 3 Clinically, hypoxia may be encountered at high altitudes, 4 during childbirth, deep-sea diving, as a complication during surgery, with a sedative over dose, or because of carbon monoxide poisoning. Fur thermore, hypoxia has been identified as an avoidable extracranial factor associated with apnea due to head injury 5 which, when controlled, could prevent severe hypoxic brain damage and ultimately minimize mor tality. 6 In each of these conditions the cerebral hypoxic damage is probably caused by lactic acid accumulation in the brain tissue which can lead to altered membrane structure and function, breakdown of blood brain bar rier and to brain edema. 7 A variety of compounds are being evaluated as pos sible therapeutic agents for hypoxia. Our laboratory, for example, has shown that pretreatment with 1,3butanediol (BD), a non-toxic ethanol dimer, 8-10 signifi cantly increases the tolerance of mice to hypoxia. 11 Diazepam, presently administered as a therapeutic in tervention in treating ischemia or hypoxia, reportedly provides this effect through its anticonvulsant proper ties and thereby presumably increases hypoxic toler ance by decreasing the brain's oxygen requirements. 12 It has been hypothesized that nimodipine, a calcium antagonist, may protect the brain from hypoxic dam age because of its ability to increase cerebral blood flow. 13 In evaluating the diluents of these potentially therapeutic agents (nimodipine and diazepam) it be came apparent that ethanol was a common component to each. The present study, therefore was designed to test the hypothesis that ethanol alone, or in diluents of these drugs plays an important role in increasing the tolerance of the brain to hypoxia.
Materials and Methods
The animal model used has been previously de scribed by Wilhjelm and Arnfred, 14 Steen and Michenfelder, 15 and used by our laboratory. 111617 White, male, albino, Sprague-Dawley, mice (HA-ICR) weighing between 20 and 40 g (free access to food and water) were exposed to premixed gases (4.62 and 8.61% oxygen) with varying intervals between pre treatment and hypoxia. The pretreatment involved i.v. or i.p. injection of saline; ethanol; nimodipine; diaze pam; complete diluents of diazepam and nimodipine; as well as incomplete diluent formulations without the citrate, propylene glycol 400 or ethanol. 2 ). Incomplete diluents were prepared on the basis of concentrations given on the manufacturer in formation sheets; nimodipine diluent was supplied by the manufacturer. All injections were given 30 minutes prior to hypoxia. In a separate series of experiments nimodipine was injected i.p. at a dose of 2 mg/kg 0, 5, 15, 22.5, 30, and 45 minutes before hypoxia to deter mine which time interval between injection and hy poxia produced the maximum protective effect.
Experimental Hypoxia
For each trial, 2 saline injected and 3 drug pretreated animals were tested simultaneously. Each mouse was placed in an airtight 110 ml flow-through chamber. Five chambers were mounted in parallel and continu ously flushed with compressed air or premixed gas. The importance of simultaneously testing control and treated mice was recently restated in a critical assess ment of this animal model by Artru and Michenfelder. 18 The diurnal variation in hypoxic tolerance reported by Stufel et al. 19 also focuses on the need for simultaneous testing of control and treated animals. 
Results
The major result of this study is that ethanol pro longs hypoxic survival in mice. This potentially thera peutic effect was identified when testing the diluents of diazepam and nimodipine. The principle active com ponent of the diluents appears to be ethanol which when given alone, either i.v. or i.p., offers significant protection from hypoxia. Figure 1 shows a statistically significant (p < 0.01) increase in hypoxic survival time from 110 ± 11 (sa line treated) to 773 ± 52 seconds (6 mice surviving past 15 minutes) when diazepam (50 mg/kg) is given 30 minutes prior to hypoxia. The ethanol-containing diluent for diazepam, the composition of which is giv en in table 1, shows a statistically significant (p < 0.01) increase in survival time to 518 ± 66 seconds (1 mouse surviving past 15 minutes).
In figure 2 an increase in survival time following the injection of 2 mg/kg nimodipine is presented at 5, 15, 22.5, 30, and 45 minutes after injection. This figure shows that nimodipine produced a significant increase from control at 3 of the 6 times tested and waiting 30 minutes to the onset of hypoxia results in the maximum protective effect (180% of saline controls). The eth anol-containing diluent for nimodipine produced a sta tistically significant increase from saline control at each time point reaching a maximum at 5 minutes postinjection. In addition, the nimodipine diluent in creased (p < 0.05) hypoxic tolerance over nimodipine, as supplied by the manufacturer, in four of the five time points tested.
In figure 3 hypoxic survival time is given as percent of saline control for diazepam, nimodipine, their dilu ents and ethanol. The diluents of these two compounds are compared to ethanol alone at a concentration (see table 1) equivalent to that in the diluents. In the case of diazepam the ethanol in the diluent, when given alone, can account for 28.6% of the protective effect and the complete diluent can account for 67.0% of the total effect. The situation is very different with nimodipine. Nimodipine, its diluent or simply the ethanol in the diluent produce increased survival times which were not significantly different from one another yet each was different from saline control. This suggests that nimodipine does not add to the protective effects of ethanol.
In an attempt to further clarify which components of these diluents, other than ethanol, were important in hypoxic protection, citrate, water and saline combina tions were tested. The data in table 2 indicates that there is a protective effect of ethanol and citrate but propylene glycol 400 does not appear to be protective.
In figure 4, dose-response relationships for ethanol in citrate, water, or saline indicate, in each case, a dosedependant increase in survival time reaching a maxi mum at a dose of approximately 1.6 mmol/mouse. The maximum protection by ethanol in water (308% of control) was greater than the maximum for ethanol in saline (211% of control). At 1.3 to 1.7 mmol/mouse the citrate and water solutions both showed a statisti cally significant (p < 0.01) increase over ethanol in saline solutions.
Because the drugs and their diluents were given either i.v. or i.p. both modes of administration of eth anol had to be tested. In figure 5, a 
Discussion
Our laboratory has demonstrated that an ethanol dimer, 1,3-butanediol is more effective in protecting mice from hypoxia than diazepam 11 and more effective than the protection reported for barbiturates. 15 Hypoxic survival time in mice is used by numerous investiga tors as a model for cerebral hypoxia to evaluate the efficacy of a variety of compounds in anticipation of identifying materials that could be considered clinical ly useful in protecting the brain from hypoxic dam age. u - 15 The assumption in all studies using this model is that the hypoxic insult involves the brain first and only secondarily cardiac function. Clinically, hypoxia is associated with drowsiness, disorientation and loss of consciousness, respiratory stimulation followed by respiratory depression and apnea. If the respiratory depression or apnea is not counteracted by artificial ventilation then the hypoxia will progress to anoxia and cardiovascular collapse. The precipitating factor in either event is the cessation of ventilation due to inadequate oxygen supply and loss of brain function. The protection offered by these compounds must in part counteract this loss of brain function due to hy poxia. This does not exclude the possibility that these same agents might also be of potential benefit to the myocardium under similar conditions. The new information in this study is not the identifi cation of yet another compound to be considered, but drawing attention to a material so commonly used that its pharmacological activity is often ignored. Emerson in 1942 20 was apparently the first to describe the pro tection from hypoxia provided by ethanol. We have confirmed this and have shown that two unrelated compounds, diazepam and nimodipine, both of which protect the hypoxic brain do so in part because of the ethanol in their diluents. Indeed, in the case of nimodi pine, the compound actually appears to have no effect on survival time since nimodipine treated mice had survival times not different from those of mice treated with ethanol alone.
The major weakness in this study is that no mecha nistic explanation for the increase in hypoxic survival time is identified. It is, however, the descriptive nature of the study that is of particular importance. Clearly any attempt to identify a mechanism of action for diaz epam or nimodipine, in protecting the brain from hy poxia, would be misguided if the pharmacological ac tivity of ethanol were to be ignored. Thus, although we do not understand the mechanism or mechanisms re- sponsible for the increase in tolerance to hypoxia dur ing diazepam, nimodipine or ethanol administration, the increases in survival time is evidently heavily de pendent on the alcohol. In that 1,3-butanediol is a dimer of ethanol and is also effective in protecting the brain we offer some speculation as to possible common modes of action of these two alcohols. With ethanol, as with 1,3-butanediol, 11 a clear dose response relationship of increasing hypoxic tolerance with increasing dose is obtained. Both produce periph eral vasodilation and hypothermia which could lower whole body metabolism 21, 22 and produce a generalized reduction in the demand for oxygen. In previous stud ies, however, the hypothermic effect of butanediol ac counted for only part of the protective effect of this alcohol. 11 Alternatively, the generalized central ner vous system anticonvulsant 23, 24 and depressant effects of alcohols could contribute to the protective effect by a direct reduction of brain oxygen demand and func tion. 25 This mechanism was explored in preliminary studies which indicate that the effect of 1,3-butanediol on brain tissue metabolites is not similar to that seen with other central nervous system depressants like bar biturates 26, 27 or ethanol. 28 Another potentially significant similarity in the bio logical effects of ethanol and its dimer 1,3-butanediol" is that both compounds have been reported to produce a systemic ketosis. 29 Based on studies in our and other laboratories 4,30,31, 32 we have developed a hypothesis which contends that ketosis increases the brain's toler ance to hypoxia, by shifting the energy producing sub strate metabolism towards ketone utilization thus mini mizing the deleterious accumulation of brain lactic acid during hypoxia. The current data does not test this hypothesis but is consistent with previous data which led to its development.
DOSE RESPONSE OF ETHANOL vs. HYPOXIC SURVIVAL TIME
The effects of the citrate buffer were not as dramatic as the ethanol effects however it is interesting to note that some protection was offered. With the present data there is no way to distinguish blood buffering, tissue buffering or osmotic effects from some more complex involvement of citrate in brain metabolism. Under conditions of head or spinal cord injury the use of ethanol or related alcohols to protect from hypoxic injury may be contraindicated in that more extensive damage has been reported in animals pretreated with these compounds. 33 Our results might therefore be more relevant to hypoxia uncomplicated by central nervous system trauma.
In conclusion our data confirm that of earlier stud ies 20 by indicating that ethanol offers significant pro tection from hypoxia. By contributing to the apparent protection offered by currently used therapeutic agents, ethanol has undoubtedly confounded the inter pretation of their mechanism of action. Although the specific mechanism of action has not been fully estab lished the similarities between ethanol and BD suggest that this family of compounds may protect the hypoxic brain through a common mode of action.
